Document Detail


What's new in atopic eczema? An analysis of systematic reviews published in 2009-2010.
MedLine Citation:
PMID:  21718344     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This review provides a summary of key findings from 18 systematic reviews on atopic eczema, published or indexed between January 2009 and 24 August 2010. There was no good evidence on the possible benefit of organic food consumption and eczema. Maternal intake of fish or fish oil may be associated with a reduced risk of eczema in offspring, although further studies are needed. There is some evidence that partially hydrolysed infant formulas rather than standard formulas may be associated with a reduced risk of eczema in infants, but there are shortcomings in the existing evidence. An inverse relationship has been found between gliomas/acute lymphoblastic leukaemia and allergic disease/eczema, but there appears to be no association between multiple sclerosis and eczema. Attention deficit hyperactivity disorder does appear to be associated with eczema, but there is no evidence of a causal link. The risk of eczema seems to be increased in urban compared with rural areas. Some new evidence has suggested superiority of 1% pimecrolimus over potent and mild corticosteroids at 6 months but not 12 months, and there is some evidence for superiority of 0.03% and 0.1% tacrolimus over 1% pimecrolimus. An updated Cochrane Review still found no evidence of a benefit from any form of antistaphylococcal treatment in managing clinically infected or uninfected eczema. The evidence base is poor for bath emollients, occlusive treatments (e.g. wet and dry wraps) and woven silk clothing in treating eczema. In general, the methods used in most systematic reviews of eczema need to be reported more clearly, especially with regard to a more vigorous quality assessment of included studies. Included studies are frequently heterogeneous, proxy reporting is common, and appropriate disease definitions are often lacking. Better adherence to existing guidance on trial reporting and prospective registration of clinical trials may help improve the quality of studies.
Authors:
K Shams; D J C Grindlay; H C Williams
Related Documents :
22529554 - Tessier 30 facial cleft.
22567494 - Restoration of fertility after removal of extrauterine mirena coil: a case report and r...
6310104 - Myalgic encephalomyelitis--report of an epidemic.
22847464 - Discordant presentation of biliary atresia in premature monozygotic twins.
10894384 - Cartilage and bone containing benign mesenchymoma of the thigh and popliteal fossa.
24324194 - Should suspected cervical spinal cord injuries be immobilised? a systematic review prot...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-1
Journal Detail:
Title:  Clinical and experimental dermatology     Volume:  -     ISSN:  1365-2230     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7606847     Medline TA:  Clin Exp Dermatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© The Author(s). CED © 2011 British Association of Dermatologists.
Affiliation:
Alan Lyell Centre for Dermatology, Southern General Hospital, Glasgow, UK NHS Evidence Skin Disorders, Centre for Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunohistochemical characterization of gamma-secretase activating protein expression in Alzheimer's...
Next Document:  What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010.